Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
University Hospital, Linkoeping Merck |
---|---|
Information provided by: | University Hospital, Linkoeping |
ClinicalTrials.gov Identifier: | NCT00860587 |
The objectives of the study were:
Condition |
---|
Complicated Intra-Abdominal Infections |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Risk Factors for Colonization and Infection With Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections (IAI). An Open Observational Study |
Estimated Enrollment: | 200 |
Study Start Date: | February 2006 |
Estimated Study Completion Date: | October 2009 |
Estimated Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |
In order to evaluate if standard empirical treatment was adequate in relation to resistance pattern among most prevalent species at admission we need another 70 patients to be included with at least data and cultures from admission.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients with evidence of severe intra-abdominal infections.
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Division of Infectious Diseases, University Hospital, SE-581 85 Linköping ( Professor Håkan Hanberger ) |
Study ID Numbers: | Bakki |
Study First Received: | March 11, 2009 |
Last Updated: | March 11, 2009 |
ClinicalTrials.gov Identifier: | NCT00860587 History of Changes |
Health Authority: | Sweden: Regional Ethical Review Board |
Antibiotic resistance Antibiotic treatment |
Anti-Infective Agents Anti-Bacterial Agents |
Anti-Infective Agents Anti-Bacterial Agents Communicable Diseases |
Therapeutic Uses Infection Pharmacologic Actions |